Latest Materials News

Tesoro Gold has completed its 80-hole infill drilling at the Ternera Gold Deposit, delivering multiple wide, high-grade gold intercepts that underpin an imminent resource upgrade and maiden Ore Reserve.

PlaySide Studios reversed a prior-year loss with a 13% revenue increase to $54.9 million and a 144% jump in net profit to $5.4 million, driven by strong Original IP sales and a strategic cost restructure.

Albion Resources has uncovered exceptionally high-grade gold at its Gidgee Gold Project, with rock-chip sampling returning a standout 280.3 g/t Au from the Phar Lap Prospect, setting the stage for a maiden drilling campaign.

Brambles Limited posted a 6% rise in sales revenue to US$7.04 billion for FY26, navigating US repair bottlenecks with decisive investments and reaffirming growth targets for FY27 and beyond.

Australian Finance Group (ASX:AFG) reported a 39% jump in FY26 net profit after tax to AUD 48.5 million, driven by growth across its broker network and lending book, alongside its first mandatory climate disclosures.

Heartland Group Holdings delivered a striking 140% jump in net profit for FY2026, underpinned by margin gains and asset quality improvements, while advancing a transformative merger with TSB to create a major New Zealand challenger bank.

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

MA Credit Income Trust (ASX: MA1) launches a voluntary off-market buy-back for up to 2.5% of units at net asset value, aiming to provide liquidity and capital management benefits to unitholders.

Ironbark Balanced Income Limited reported a 5.6% decline in net profit to $2.89 million for FY2026, while its investment portfolio delivered a solid 7.8% return, outperforming its benchmark and maintaining fully franked dividends.

Energy Fuels’ acquisition of Australian Strategic Materials (ASM) has officially closed following Federal Court approval, triggering suspension of ASM trading and setting the stage for shareholder payments and new listings.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.